Infant Botulism Outbreak Linked to ByHeart Formula: November 2025

Nov 29, 2025, 3:21 AM
Image for article Infant Botulism Outbreak Linked to ByHeart Formula: November 2025

Hover over text to view sources

A significant outbreak of infant botulism has been linked to ByHeart Whole Nutrition infant formula, with 37 cases reported across 17 states as of November 26, 2025. The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are actively investigating the situation, which has resulted in a nationwide recall of all ByHeart formula products.
The outbreak was first identified when the California Department of Public Health (CDPH) noted an increase in infant botulism cases potentially associated with ByHeart formula. Preliminary testing indicated the presence of Clostridium botulinum, the bacterium responsible for the illness, in both opened and unopened containers of the formula.
Symptoms of infant botulism typically begin with constipation, poor feeding, and loss of head control. If untreated, the condition can progress to severe respiratory issues and potentially lead to respiratory arrest. All 37 infants affected by this outbreak were hospitalized, although no fatalities have been reported to date.
The CDC has confirmed that the illnesses began between August 9 and November 19, 2025. The affected infants range in age from 16 to 264 days, with a notable portion being female. Health officials are conducting interviews with caregivers to trace the consumption of ByHeart formula prior to the onset of symptoms.
In response to the outbreak, ByHeart has recalled all of its infant formula products, including both cans and single-serve packets. The FDA has reported that the recalled formula was still being found on store shelves in various states, including major retailers such as Walmart, Target, and Kroger. The agency is collaborating with state partners to ensure that these products are removed from circulation effectively.
Parents and caregivers are advised to stop using any ByHeart infant formula immediately and to monitor their infants for symptoms of botulism. If symptoms develop, they should seek medical attention without delay. The CDPH has set up a hotline for concerned parents, available daily from 7 am to 8 pm PST, to provide guidance and support.
The investigation is ongoing, with further testing being conducted to determine the exact source of contamination. The FDA has also begun releasing inspection reports from ByHeart facilities to shed light on potential lapses in safety protocols.
Infant botulism is rare but can be life-threatening. It occurs when infants ingest spores of Clostridium botulinum, which then grow in their intestines and produce toxins. The antitoxin BabyBIG is available as a treatment, and early recognition and intervention are critical for improving outcomes.
As this situation develops, health officials are urging parents to remain vigilant and to report any suspected cases of infant botulism immediately to local health authorities. The CDC and FDA will continue to provide updates as more information becomes available, emphasizing the importance of public awareness in preventing further cases.
In conclusion, this outbreak highlights the critical need for stringent safety measures in infant food products and the importance of rapid response from health authorities in managing public health crises.

Related articles

Flu Cases Surge in Massachusetts: Health Tips for the Season

Flu cases are rising sharply in Massachusetts, particularly among children, prompting health officials to urge vaccinations and preventive measures. With the holiday season underway, residents are encouraged to take steps to protect themselves and their families from the flu.

Amgen Collaborates with U.S. Government to Reduce Drug Prices

Amgen has announced a partnership with the US government to lower prescription drug prices, expanding its AmgenNow™ program to offer significant discounts on key medications. This initiative aligns with the government's Most Favored Nation pricing policy, aiming to make essential medicines more affordable for American patients.

Federal Government Sues Advocate Aurora Health Over Vaccine Policy

The US Equal Employment Opportunity Commission has filed a lawsuit against Advocate Aurora Health, alleging the health system discriminated against a nurse by denying her a religious exemption from the COVID-19 vaccine mandate. The lawsuit seeks reinstatement, back pay, and changes to the health system's policies.

Strategies to Mitigate Rising Health Care Costs in the U.S.

Health care costs in the US are surging, driven by various factors including for-profit practices and increased demand post-pandemic. Strategies such as expanding telemedicine, reforming insurance structures, and addressing pharmaceutical pricing could help alleviate these financial burdens.

Kennedy Plans Overhaul of Childhood Vaccine Schedule

Health Secretary Robert F. Kennedy Jr is set to announce a significant overhaul of the childhood vaccination schedule in the US, proposing fewer vaccines in alignment with countries like Denmark. This change has raised concerns among medical experts about potential public health risks and the implications for vaccine accessibility.